DRW Securities LLC Purchases Shares of 5,179 Centene Co. (NYSE:CNC)

DRW Securities LLC acquired a new stake in Centene Co. (NYSE:CNC) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 5,179 shares of the company’s stock, valued at approximately $314,000.

Several other institutional investors have also recently added to or reduced their stakes in the business. Capital Advisors Ltd. LLC increased its stake in shares of Centene by 75.3% during the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock valued at $25,000 after acquiring an additional 177 shares during the last quarter. Hurley Capital LLC acquired a new position in Centene during the fourth quarter worth approximately $26,000. Rialto Wealth Management LLC acquired a new position in shares of Centene in the 4th quarter valued at $30,000. OFI Invest Asset Management purchased a new stake in shares of Centene during the 4th quarter valued at $33,000. Finally, SRS Capital Advisors Inc. increased its holdings in shares of Centene by 73.4% during the 4th quarter. SRS Capital Advisors Inc. now owns 631 shares of the company’s stock worth $38,000 after buying an additional 267 shares during the last quarter. 93.63% of the stock is currently owned by institutional investors and hedge funds.

Centene Stock Performance

Shares of CNC stock opened at $62.46 on Friday. The stock has a market capitalization of $30.98 billion, a price-to-earnings ratio of 10.01, a PEG ratio of 0.80 and a beta of 0.53. Centene Co. has a one year low of $55.03 and a one year high of $80.59. The company’s 50-day simple moving average is $59.44 and its 200-day simple moving average is $61.80. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.10 and a current ratio of 1.11.

Centene (NYSE:CNC) last issued its earnings results on Tuesday, February 4th. The company reported $0.80 EPS for the quarter, topping the consensus estimate of $0.49 by $0.31. Centene had a return on equity of 13.85% and a net margin of 2.03%. The company had revenue of $40.81 billion during the quarter, compared to analyst estimates of $38.78 billion. During the same quarter last year, the firm earned $0.45 EPS. The business’s revenue was up 3.4% on a year-over-year basis. Equities analysts anticipate that Centene Co. will post 6.86 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have commented on CNC shares. Stephens dropped their price target on Centene from $75.00 to $73.00 and set an “equal weight” rating for the company in a research note on Friday, December 13th. Argus lowered shares of Centene from a “buy” rating to a “hold” rating in a report on Thursday, February 6th. Truist Financial decreased their price target on shares of Centene from $89.00 to $84.00 and set a “buy” rating for the company in a research report on Friday, December 13th. Guggenheim initiated coverage on Centene in a research note on Wednesday. They set a “neutral” rating on the stock. Finally, StockNews.com lowered Centene from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 6th. Seven research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $80.85.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.